Iphepha elingasikwanga leMalariya yezoNyango kwifektri yePF

inkcazelo emfutshane:

I-Antibody ye-IgM ukuya kwi-Mycoplasma Pneumoniae Iphepha elinganqunyulwanga
Indlela yokusebenza:Igolide yeColloidal


  • Indlela yokusebenza:Igolide yeColloidal
  • Ukupakisha:200pcs / ibhegi
  • Isampulu :ekhoyo
  • Iinkcukacha zeMveliso

    Iithegi zeMveliso

    INGCACISO YEMVELISO

    Inombolo yoMzekelo Ishiti elingasikwanga
    Ukupakisha 50 sheet ngebhegi
    Igama Iphepha elingasikwanga lovavanyo olukhawulezayo lweMalariya Ukuhlelwa kwesixhobo Udidi II
    Iimbonakalo Uvakalelo oluphezulu, ukusebenza ngokulula Isatifikethi CE/ISO13485
    Ukuchaneka > 99% Beka ubomi kwishelufa Iminyaka emibini
    Indlela yokusebenza Igolide yeColloidal
    iphepha elingasikwanga

    Ukongama

    Iphepha elingasikwanga elisemgangathweni leMalaria PF
    Uhlobo lomfanekiso : Igazi elipheleleyo

    Ixesha lokuvavanya: 15 -20mins

    Ugcino:2-30℃/36-86℉

    Indlela yokusebenza:Igolide yeColloidal

     

     

    Uphawu:

    • Uvakalelo oluphezulu

    • iziphumo zokufunda kwimizuzu eyi-10-15

    • Ukusebenza ngokulula

    • Ukuchaneka okuphezulu

     

    I-calprotectin yephepha elingasikwanga

    UKUSETYENZISWA OKUHLOSIWEYO

    Le khithi isetyenziswa ekubhaqweni komgangatho we-in vitro we-antigen kwi-plasmodium falciparum histidine-rich proteins II(HRP II), kwaye isetyenziselwa uxilongo oluncedisayo losulelo lwe-plasmodium falciparum (pf). Le khithi ibonelela kuphelaI-histidine-rich proteins II (HRP II) isiphumo sokufumanisa i-antigen, kwaye iziphumo ezifunyenweyo ziya kusetyenziswa ngokudibanisa nolunye ulwazi lweklinikhi ukuhlalutya.

    Umboniso

    umboniso
    Global-iqabane

  • Ngaphambili:
  • Okulandelayo: